The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > BUSINESS
BUSINESS
- Diovan Data Manipulation Case Closed, Ruling Due Out in March
December 16, 2016
- Shinjiro Sato Tapped as Next President of Terumo
December 16, 2016
- Aspen Japan, Kissei Sign Copromotion Pact on Imuran
December 16, 2016
- Fujifilm to Acquire Takeda’s Reagent Unit for 155 Billion Yen
December 16, 2016
- Nippon Kayaku Introduces “MSLs” to Strengthen Detailing for Oncology Generics, Biosimilars, and Products in Development
December 16, 2016
- Interview: GSK’s New Evaluation System for Sales Reps Helps Deliver Science-Based Message
December 15, 2016
- FunPep, Shionogi Enter Joint Research Agreement for Vaccine Adjuvants
December 15, 2016
- Daiichi Sankyo Aims to File Antibody Drug Conjugate DS-8201 in 2020 for HER2-Positive Breast Cancer, Stomach Cancer
December 15, 2016
- Parkinson’s Med Nouriast Fails in PIII Study in US, Europe: Kyowa Kirin
December 14, 2016
- Daiichi Sankyo Links Arms with DarwinHealth on Cancer R&D
December 14, 2016
- Entyvio Delivers Higher Response Rates as 1st Line Biologic
December 13, 2016
- Astellas Europe to Transfer Rights for Pain Med Qutenza to Grünenthal
December 13, 2016
- Eisai’s BACE Inhibitor Cuts Beta Amyloid by 70% at 50 mg Daily
December 13, 2016
- Biogen Japan Seeks Japan Approval for Nusinersen
December 13, 2016
- Aspen Japan Starting on Right Foot on AG Biz: GSK Japan President
December 13, 2016
- Development of Novel Myeloid Leukemia Drug Gilteritinib Makes Progress: Astellas
December 12, 2016
- Mitsubishi Tanabe Wants to Make a Challenge in Experienced Field, President Says on Licensed Cell Therapy
December 9, 2016
- Nippon Kayaku Wins Reversal in Elplat Patent Suit
December 9, 2016
- Keytruda Launch Planned in Early Next Year: MSD Japan Chief
December 9, 2016
- Pfizer’s “Established” Pharma Business Expands to “Essential Health” to Include New Drugs, Copromoted Products
December 9, 2016
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…